Skip to main content
Clinical Trials/ISRCTN11057518
ISRCTN11057518
Completed
未知

A randomised controlled trial to assess the impact of a lifestyle intervention (ActWELL) in women invited to NHS breast screening

niversity of Dundee0 sites560 target enrollmentJuly 21, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Body weight and physical activity
Sponsor
niversity of Dundee
Enrollment
560
Status
Completed
Last Updated
last year

Overview

Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30413516 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32503606/ feasibility and optimisation results (added 08/06/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33676538/ (added 18/06/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34090495/ Letter (added 05/08/2024) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33968362/ SWAT 76 evaluation (added 05/08/2024)

Registry
who.int
Start Date
July 21, 2017
End Date
December 31, 2019
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of Dundee

Eligibility Criteria

Inclusion Criteria

  • 1\. Invited to attend, or attended, routine breast screening clinics (not recall clinics)
  • 2\. Measured BMI \>25 kg/m2
  • 3\. Women aged 50\-70 years

Exclusion Criteria

  • 1\. Currently undergoing treatment for any malignant condition
  • 2\. Reported contra\-indication to physical activity (e.g. recent surgery)
  • 3\. Reported contra\-indication to weight management (e.g. currently following a recovery programme for weight gain)
  • 4\. Diagnosis of Type 1 diabetes
  • 5\. No telephone contact
  • 6\. Current use of insulin
  • 7\. Unable to consent
  • 8\. On a special or prescribed diet e.g. gluten free

Outcomes

Primary Outcomes

Not specified

Similar Trials